ArticleDrug delivery and translational research2022

Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting.

Monica Argenziano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.